RecruitingNCT05529927
Extended-release dexamphetamine or placebo for cocaine use during opioid treatment
About this title
Efficacy and Safety of Sustained-release Dexamphetamine in Patients With Moderate to Severe Cocaine Use Disorder
Read the official source — NCT05529927Medication studyAges 18+NetherlandsAddiction
Understand this study
Who could participate?
Listed age limits: from 18 years.
- Listed locations
- The HagueSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: April 22, 2026
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 204
- Sponsor
- Parnassia Addiction Research Centre
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Netherlands
- Age range
- Over 18 Years
- Official registry ID
- NCT05529927
- Official title
Show the full official title
Efficacy and Safety of 24 Weeks Sustained-release Dexamphetamine in Patients With Moderate to Severe Cocaine Use Disorder With Comorbid Opioid Use Disorder - A Multicenter Randomized, Double-blind, Placebo-controlled Study
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
The Hague
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Parnassia Addiction Research Centre, a research institute.
Does this study involve medication?
Yes. The study involves medication, including Sustained-release Dexamphetamine and Placebo.
Who can participate?
Listed age limits: from 18 years.
Is this study still recruiting?
The registry lists this study as recruiting.
